Kinderneusdruppels Xylometazoline Hcl Htp (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride acts on the nasal mucosa to reduce swelling and improve airflow in several common conditions.

• Nasal congestion: decreases mucosal edema and restores normal breathing.
• Common cold: alleviates blockage and pressure caused by viral upper‑respiratory infection.
• Allergic rhinitis: provides temporary relief of nasal obstruction during allergic episodes.

• Xylometazoline Hydrochloride selectively stimulates alpha‑adrenergic receptors on the smooth muscle of nasal mucosal blood vessels, causing vasoconstriction. This reduces blood flow, limits plasma exudation, and diminishes tissue edema, leading to decreased nasal congestion and improved airway patency.

Adverse reactions may occur with the use of nasal decongestant drops.

Common Side Effects

• Nasal irritation or burning sensation.
• Dryness of the nasal mucosa.
• Sneezing.
• Headache.
• Altered taste perception.
• Transient epistaxis.

Serious or Rare Side Effects

• Severe hypertension or hypertensive crisis.
• Cardiac arrhythmias.
• Nasal septum perforation with prolonged use.
• Allergic reactions including anaphylaxis.
• Paradoxical rebound congestion (rhinitis medicamentosa).
• Ocular irritation if the product contacts the eyes.

Before using this nasal decongestant, consider the following safety measures.

• Pediatric use: follow age‑appropriate dosing guidance from a healthcare professional.
• Duration of therapy: limit use to no more than three consecutive days to avoid rebound congestion.
• Hypertension: contraindicated in patients with severe uncontrolled high blood pressure.
• Cardiovascular disease: use with caution in patients with heart disease or arrhythmias.
• Nasal surgery: avoid use immediately before or after nasal surgical procedures.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other medications that affect vascular tone or blood pressure.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
• Sympathomimetic agents (e.g., pseudoephedrine): additive vasoconstrictive effect.
• Tricyclic antidepressants: may increase cardiovascular side effects.

Moderate Interactions (Monitor Closely)

• Antihypertensive drugs: possible reduction in blood‑pressure‑lowering effect.
• Other nasal decongestant sprays or drops: risk of cumulative vasoconstriction and rebound congestion.
• Alcohol: may enhance dizziness or drowsiness.
• Herbal decongestants (e.g., ephedra): additive sympathomimetic activity.